Nov 22, 2017 13:31 pm UTC| Business
Please find enclosed the presentation of Frontline Ltd.'s third quarter 2017 results. Frontline Ltd. Hamilton, Bermuda November 22, 2017 This information is subject to the disclosure requirements pursuant to section 5...
Ideal Power to Present at the 10th Annual LD Micro Main Event on December 5, 2017
Nov 22, 2017 13:31 pm UTC| Business
AUSTIN, Texas, Nov. 22, 2017 -- Ideal Power Inc. (NASDAQ:IPWR), an innovative power conversion technology company, has been invited to present at the 10th Annual LD Micro Main Event being held on December 5-7, 2017 at...
Vilacto Bio Inc. speeds up cooperation with Pharma GP to reach higher targets
Nov 22, 2017 13:30 pm UTC| Business
COPENHAGEN, Denmark, Nov. 22, 2017 -- Vilacto Bio Inc. (OTC QB:VIBI), is pleased to announce that within the next 3 month, the company will be taking over the online sales from Pharma GP direct to customers outside of...
CHF Solutions, Inc. Announces Pricing of $18.0 Million Underwritten Public Offering
Nov 22, 2017 13:30 pm UTC| Business
EDEN PRAIRIE, Minn., Nov. 22, 2017 -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today the pricing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds...
County Bancorp, Inc. Declares Dividend
Nov 22, 2017 13:30 pm UTC| Business
MANITOWOC, Wis., Nov. 22, 2017 -- County Bancorp, Inc. (NASDAQ:ICBK), the parent company for Investors Community Bank, announced that on November 21, 2017 its Board of Directors declared a quarterly cash dividend of...
Nov 22, 2017 13:30 pm UTC| Business
NEW YORK, Nov. 22, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of bluebird bio, Inc....
Teligent, Inc. Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1%
Nov 22, 2017 13:30 pm UTC| Business
BUENA, N.J., Nov. 22, 2017 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA)...